• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝门部胆管癌切除术]

[Resection of Klatskin tumors].

作者信息

Seehofer D, Kamphues C, Neuhaus P

机构信息

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland.

出版信息

Chirurg. 2012 Mar;83(3):221-8. doi: 10.1007/s00104-011-2177-6.

DOI:10.1007/s00104-011-2177-6
PMID:22406679
Abstract

Curative treatment of Klatskin tumors by radical surgical procedures with surgical preparation distant to the tumor region results in 5-year survival rates of 30-50%. This requires mandatory en bloc liver resection and resection of the extrahepatic bile duct often together with vascular resection. Nevertheless, the ideal safety margin of 0.5-1 cm remote from the macroscopic tumor extensions cannot be achieved in all cases. Based on hilar anatomy the probability of an adequate safety margin is higher using extended right hemihepatectomy together with portal vein resection compared to left hemihepatectomy. However, due to severe atrophy of the left liver lobe solely left-sided hepatectomy is feasible in some patients. In cases of eligibility for both procedures right hemihepatectomy is preferentially used due to the higher oncological radicality if sufficient liver function is present. Postoperative hepatic insufficiency and bile leakage after demanding biliary reconstruction, often with several small orifices, contribute to the postoperative complication rate of this complex surgical disease pattern.

摘要

通过远离肿瘤区域进行手术准备的根治性手术对肝门部肿瘤进行根治性治疗,5年生存率为30%-50%。这需要进行整块肝切除,肝外胆管切除通常还需联合血管切除。然而,并非所有病例都能实现距肉眼可见肿瘤边缘0.5-1厘米的理想安全切缘。基于肝门部解剖结构,与左半肝切除相比,扩大右半肝切除联合门静脉切除获得足够安全切缘的概率更高。然而,由于左肝叶严重萎缩,部分患者仅行左侧肝切除也是可行的。在两种手术方式均适用的情况下,如果肝功能足够,优先选择右半肝切除,因为其肿瘤根治性更高。在进行复杂的胆道重建(通常有多个小孔)后,术后肝衰竭和胆漏会导致这种复杂手术疾病模式的术后并发症发生率升高。

相似文献

1
[Resection of Klatskin tumors].[肝门部胆管癌切除术]
Chirurg. 2012 Mar;83(3):221-8. doi: 10.1007/s00104-011-2177-6.
2
[Perihilar cholangiocarcinoma (Klatskin tumor)].[肝门部胆管癌(克氏瘤)]
Chirurg. 2014 Feb;85(2):155-65; quiz 166-7. doi: 10.1007/s00104-012-2390-y.
3
Robotic Klatskin Type 3A Resection with Biliary Reconstruction: Description of Surgical Technique and Outcomes of Initial Series.机器人 Klatskin 型 3A 切除术联合胆道重建:手术技术描述及初步系列结果。
Ann Surg Oncol. 2023 Dec;30(13):8559-8560. doi: 10.1245/s10434-023-14256-y. Epub 2023 Sep 8.
4
[Klatskin tumor. A study of 15 resected cases].[肝门部胆管癌。15例手术切除病例的研究]
Chirurgie. 1999 Apr;124(2):132-9; discussion 139-40. doi: 10.1016/s0001-4001(99)80055-5.
5
Robotic Right Hepatectomy with En Bloc Caudatectomy for Bismuth IIIa Hilar Cholangiocarcinoma: A Video Demonstration of Left-Liver-First Anterior Radical Modular Orthotopic Right Hemihepatectomy.机器人辅助右半肝切除联合尾叶整块切除术治疗 Bismuth IIIa 型肝门部胆管癌:左肝优先前入路左半肝模块化标准右半肝切除术的视频演示
Ann Surg Oncol. 2024 Sep;31(9):5636-5637. doi: 10.1245/s10434-024-15407-5. Epub 2024 May 16.
6
Right trisectionectomy with principle en bloc portal vein resection for right-sided hilar cholangiocarcinoma: no-touch technique.右三叶切除术联合整块门静脉切除治疗右肝门部胆管癌:无接触技术。
Ann Surg Oncol. 2012 Apr;19(4):1324-5. doi: 10.1245/s10434-011-2072-x. Epub 2011 Oct 15.
7
Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.单纯腹腔镜下肝门部胆管癌Ⅲa 型根治术。
Surg Endosc. 2018 Mar;32(3):1581-1582. doi: 10.1007/s00464-017-5741-4. Epub 2017 Aug 4.
8
Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video).整块肝门部胆管、左半肝及尾状叶切除术:一种治疗左侧肝门部胆管癌的新方法(附视频)
J Gastrointest Surg. 2017 Nov;21(11):1906-1914. doi: 10.1007/s11605-017-3561-4. Epub 2017 Sep 5.
9
Right hepatectomy compared with left hepatectomy for resectable Klatskin tumor: A systematic review across tumor types.右半肝切除术与左半肝切除术治疗可切除 Klatskin 肿瘤的比较:跨越肿瘤类型的系统评价。
Surgery. 2024 Oct;176(4):1018-1028. doi: 10.1016/j.surg.2024.07.001. Epub 2024 Jul 23.
10
[Surgical therapy of hilar cholangiocarcinoma].[肝门部胆管癌的外科治疗]
Chirurg. 2006 Apr;77(4):325-34. doi: 10.1007/s00104-006-1177-4.

引用本文的文献

1
Extrahepatic Intraductal Papillary Neoplasms of Bile Duct and Klatskin Tumor: Simultaneous Occurrence and Recurrence?胆管肝外导管内乳头状肿瘤与肝门部胆管癌:同时发生与复发?
ACG Case Rep J. 2024 Sep 27;11(10):e01522. doi: 10.14309/crj.0000000000001522. eCollection 2024 Oct.
2
Prediction of the Postoperative Outcome in Liver Resection Using Perioperative Serum Lactate Levels.利用围手术期血清乳酸水平预测肝切除术后结局
J Clin Med. 2023 Mar 7;12(6):2100. doi: 10.3390/jcm12062100.
3
Klatskin Tumor: A Population-Based Study of Incidence and Survival.

本文引用的文献

1
Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.术中近端胆管切缘阳性的额外切除可改善肝门部胆管癌患者的生存。
Ann Surg. 2011 Nov;254(5):776-81; discussion 781-3. doi: 10.1097/SLA.0b013e3182368f85.
2
Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.肝门整块切除术治疗肝门部胆管癌的肿瘤学优势。
Ann Surg Oncol. 2012 May;19(5):1602-8. doi: 10.1245/s10434-011-2077-5. Epub 2011 Oct 1.
3
Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study.
肝门部胆管癌:基于人群的发病率和生存研究。
Med Sci Monit. 2019 Jun 17;25:4503-4512. doi: 10.12659/MSM.914987.
4
Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma.使用三维建模对Bismuth和Corlette III型肝门部胆管癌进行个体化术前规划。
World J Surg Oncol. 2016 Feb 24;14(1):44. doi: 10.1186/s12957-016-0794-8.
5
Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.光动力疗法用于肝门部胆管癌新辅助降期——一项II期初步研究的长期结果
Int J Mol Sci. 2015 Nov 6;16(11):26619-28. doi: 10.3390/ijms161125978.
6
The diagnosis and treatment of cholangiocarcinoma.胆管癌的诊断与治疗。
Dtsch Arztebl Int. 2014 Oct 31;111(44):748-54. doi: 10.3238/arztebl.2014.0748.
7
[Perihilar cholangiocarcinoma (Klatskin tumor)].[肝门部胆管癌(克氏瘤)]
Chirurg. 2014 Feb;85(2):155-65; quiz 166-7. doi: 10.1007/s00104-012-2390-y.
动脉与门静脉栓塞用于诱导肝门部胆管癌扩大右半肝切除术前肝肥大:一项前瞻性随机研究。
J Vasc Interv Radiol. 2011 Sep;22(9):1254-62. doi: 10.1016/j.jvir.2011.04.014. Epub 2011 May 31.
4
[Hepatobiliary anastomosis techniques].[肝胆吻合技术]
Chirurg. 2011 Jan;82(1):7-10, 12-3. doi: 10.1007/s00104-010-1902-x.
5
Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.肝切除术联合门静脉和肝动脉切除治疗高位肝门部胆管癌:50 例连续病例的回顾性分析。
Ann Surg. 2010 Jul;252(1):115-23. doi: 10.1097/SLA.0b013e3181e463a7.
6
The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery.LiMAx 试验:一种新的肝功能试验,可预测肝外科术后结局。
HPB (Oxford). 2010 Mar;12(2):139-46. doi: 10.1111/j.1477-2574.2009.00151.x.
7
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.顺铂联合吉西他滨与吉西他滨治疗胆管癌。
N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.
8
Major hepatectomy for perihilar cholangiocarcinoma.肝门部胆管癌的根治性肝切除术。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):463-9. doi: 10.1007/s00534-009-0206-3. Epub 2009 Nov 26.
9
One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008.2001 年至 2008 年间,连续对 107 例 Bismuth Ⅱ型、Ⅲ型、Ⅳ型肝门部胆管癌患者进行了外科手术切除。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):470-5. doi: 10.1007/s00534-009-0207-2. Epub 2009 Nov 21.
10
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.